| ADR | adverse reaction |
| AMF | amphotericin |
| CAP | caspofungin |
| CEF/AVI | ceftazidime/avibactam |
| CI | confidence interval |
| COL | colistin |
| DI | drug ineffectiveness |
| DR | drug resistance |
| EEA | European Economic Area |
| EMA | European Medicines Agency |
| EV | EudraVigilance |
| FLU | fluconazole |
| ICSR | Individual Case Safety Report |
| ICU | intensive care unit |
| ISA | isavuconazole |
| LIN | linezolid |
| LPS | lipopolysaccharide |
| MER | meropenem |
| MOX | moxifloxacin |
| PBP | penicillin-binding proteins |
| PIP/TAZ | piperacillin/tazobactam |
| PTs | preferred terms |
| ROR | reporting odds ratio |
| TIG | tigecycline |
| VAN | vancomycin |
| VOR | voriconazole |